Share Name Share Symbol Market Type Share ISIN Share Description
Puricore Plc LSE:PURI London Ordinary Share GB00B3XBCR18 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 29.75p 28.50p 31.00p 29.75p 29.75p 29.75p 0.00 07:32:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 15.9 -6.3 -12.9 - 14.92

Puricore Share Discussion Threads

Showing 1951 to 1970 of 1975 messages
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
16/11/2016
17:55
I took today’s RNS as saying that there has been a delay on PR013 following the IND meeting with the FDA. In the October 10 RNS they referred to quote We have already made good progress this year with two INDs on track for submission in Q1 2017 unquote and now they are saying that PR013 has moved back to Q3 after the IND meeting. This repeated what they said in their September Interims announcement Quote We are on track to submit two INDs in Q1 2017. unquote Is that how everyone else reads this?
cerrito
20/9/2016
07:43
13 mil now so 50% rise needed to get to cash level or around 38-40p Not that it will, it should but when does it guarantee that happens. But it certainly should be over 30p
hatey
20/9/2016
06:46
Looks like good news.Will leave them with circa £20m cash and a very interesting drug platform.Current market cap £11m.
wigwammer
29/3/2016
15:08
mm's must be delaying the trade. 29 March 2016 PuriCore plc ("PuriCore" or the "Company") Director Dealing 29 March 2016 - PuriCore plc (AIM: PURI), announces that, Alex Martin, Chief Executive Officer and Executive Director of the Company, today purchased ordinary shares of 10p each in the share capital of the Company ("Shares"). % of Number Purchase Shareholding issued of Shares price following share Name Date purchased purchased of Shares the purchase capital 29 March Alex Martin 2016 100,000 28p 100,000 0.20%
love it
15/3/2016
15:54
" The Company expects to report full year results by the end of March 2016" Might also be a sale of business to report with those results leaving the company with way more cash than market cap. Does look very promising.
love it
14/3/2016
09:09
dream chart
love it
09/3/2016
12:00
Lovely chart
love it
16/2/2016
10:07
Moving again. Informed possible overhang has been cleared.
love it
13/2/2016
14:55
100k buy yesterday £23.4k not smallfry
love it
11/2/2016
10:42
Nice post Premier1 Company results end of March. Can see Directors buying more if price stays this low.
love it
09/2/2016
13:30
Had another 10k at 23.9p not sure I would called it a distressed seller but it looks suspicious that it's just one person dropping blocks around 25k today. Guess when they are finished the price will rise again.
love it
08/2/2016
13:58
Riddle, before bigging up any outfit, I think that it's always best to take a peek at past and current performance, especially as early investors in this POS are down almost 95% on their original investments. Two years ago, Puri had two revenue generating divisions; the loss making supermarket business and the endoscopy business which was generating $2m PBT. So, guess which one did they sold? Now they claim growing revenues in the remaining retail side (due mainly to one-off sales of dosing units), but most likely the business remains unprofitable. Solution - "Let's abandon all existing revenue streams and get into the prescription drugs business, which we know absolutely FA about, apart from what some consultant chappies have told us. And let's also recruit some suitable souls to help us spend the last of our share-holders funds as we chase some blue-sky dreams. Gosh, we're brilliant altogether, what spiffingly wonderful money managers we are"
danwaits
08/2/2016
09:18
So market cap roughly the same as cash balance,possible sale of $20m plus turnover business and a year away from two IND applications with the FDA (Q1 2017)!!!
riddlerone
04/1/2016
11:44
Lots of cash here that was decided by the board to not return to shareholders.Mr Newton is no fool and by building a large shareholding could begin to influence the direction of their decisions.
riddlerone
14/10/2015
16:27
This just might get a bit more interesting. 14 October 2015 PuriCore plc ("PuriCore" or the "Company") Director Dealing 14 October 2015 - PuriCore plc (AIM: PURI), an international company focused on applying its proprietary hypochlorous acid platform technology to unmet needs in human health, announces that, on 14 October 2015, the Director named below notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares"). % of Number Purchase Shareholding issued of Shares price following the share Name Date purchased purchased of Shares purchase capital Daniel Hegglin Non-Executive Director 13 October 2015 500,000 18p 5,909,091 11.79%
love it
14/10/2015
15:08
Looks ripe for a bounce so bought in today.
love it
23/9/2015
12:47
Now we all know. Apparently the second half is expcted to be much better.
gfrae
20/8/2015
14:34
Does anyone know why the shares are weak now - is it just "the market" or something specific ?
gfrae
19/3/2015
12:58
Maybe that his hit the nail on the head. Must be some reason for the lowly rating..
meijiman
19/3/2015
12:54
Thanks for the explanation Dan,and that may explain why the market values them at little more than the cash they have in the bank.
gfrae
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161205 18:40:58